[{"Assets_0_Q2_USD":259160000.0,"CommonStockSharesOutstanding_0_Q2_shares":41435000.0,"EarningsPerShareBasic_1_Q2_USD":0.7,"EarningsPerShareBasic_2_Q2_USD":1.33,"EarningsPerShareDiluted_1_Q2_USD":0.68,"EarningsPerShareDiluted_2_Q2_USD":1.29,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":33536000.0,"NetIncomeLoss_1_Q2_USD":28927000.0,"NetIncomeLoss_2_Q2_USD":54837000.0,"StockholdersEquity_0_Q2_USD":76728000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":42487000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":42625000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":41091000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":41233000.0,"Ticker":"AVDL","CIK":"1012477","name":"AVADEL PHARMACEUTICALS PLC","OfficialName":"Avadel Pharmaceuticals plc American Depositary Shares","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"391383731.0","Country":"France","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170809"}]